Navigation Links
ESMO in Medical News

ECCO 15 -- ESMO 34 multidisciplinary cancer congress

ECCO 15 ESMO 34 will take place at the ICC Berlin Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany ( www.icc-berlin.de ) from Sunday 20 September to Thursday 24 September 2009. ECCO 15 ESMO 34 will build on the success of the previous ECCO (European Cancer Conference) ...

2nd ESMO symposium on soft tissue carcinomas and GIST

Experts in treating a rare group of cancers that affect tissues such as muscle, fat, nerves and the gastrointestinal wall are meeting in Milan, Italy on 13-14 May to discuss the latest information on how these diseases develop and potential new avenues for therapy. The 2nd Symposium on Sarcoma ...

Handbook of cancer prevention launched by ESMO

A new publication designed to help individuals, doctors and governments reduce the global burden of cancer has been announced today by Europes leading society for medical oncologists. The ESMO Handbook of Cancer Prevention, from the European Society for Medical Oncology, contains state-of-the-a...

Transatlantic alliance supports breast cancer research

...n translational research will discuss cutting-edge treatments that are now moving from laboratories into the clinical setting. Komen will also support esmo research fellowships in preeminent cancer centers in Western Europe to offer doctors from Eastern European countries the opportunity to learn the newe...

New data on link between cancer and nutrition discussed at European symposium

.... The latest research findings on these topics will be discussed at the esmo Symposium on Cancer and Nutrition (20-21 March 2009), organized by the Euro...the advice given to people is based on proper scientific evidence." The esmo Symposium will discuss the latest evidence on the link between diet and can...

GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer

...ures 2008. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf . Accessed January 28, 2009. (2) Eichhorst B. Chronic lymphocytic leukemia: esmo Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008. 19:60-62. doi:10.1093/annonc/mdn090. (3) Leukemia and Lymphoma Soci...

Get the latest on premier science in medical oncology

...reate lively discussions on hot topics. The 7th esmo Patient Seminar where patients will have the chanc...t state-of-the-art oncology. The fifth batch of esmo Designated Centers of Integrated Oncology and Pall...llence for patient care in Europe. A session on esmo Clinical Recommendations will update current...

10th World Congress on Gastrointestinal Cancer -- Barcelona, Spain

... As it celebrates its 10th year, the esmo International Symposium: 10th World Congress on Gastrointestinal Cancer has...g the medical community and look forward to continuing the journey." The esmo International Symposium: 10th World Congress on Gastrointestinal Cancer, de...

Symposium focuses on curable cancer that affects young men

...e adopted course," Prof. Schmoll continued. The esmo Symposium on Testicular Cancer will present cuttin...eeting, the Symposium Faculty will convene for the esmo International Consensus meeting on Testicular Tumo...al important topics in the field and to update the esmo Clinical Recommendations (CR) on Testicular semino...

European Society for Medical Oncology and European CanCer Organization join forces

...n-numbered years between the ECCO-ESMO congresses, esmo will continue to hold its own esmo Congress. In 2008, the 33rd esmo Congress will take place as planned, 12-16 Septemb...
ESMO in Medical Technology

Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy

Interim data from Phase 1b Study indicate that adecatumumab in combination with docetaxel is safe and well tolerated and suggest a better outcome for breast cancer patients with high EpCAM expression BETHESDA, Md., Sept. 15 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a...

Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

LOS ANGELES--(BUSINESS WIRE)--July 8, 2007 - Cougar Biotechnology, Inc. (OTCBB:CGRB) today announced that positive Phase I and Phase II data on the Company's prostate cancer drug candidate CB7630 (abiraterone acetate) were presented at the European Society for Medical Oncology (ESMO) Conference, wh...

YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY

...; Session ID: Clinical Research 10). The abstract of this poster has been published today (09-AB-5492-AACR). "Data to be presented at the AACR and esmo conferences, combined with rash being reported independent of the KRAS status of patients, are in sharp contrast to the dated speculation that toxicit...

Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology

...ct #768O) V. Chiarion Sileni - Oral presentation from 3:30 p.m. to 5:30 p.m. local time on Monday, September 15, 2008. More information about the esmo Congress may be found at http://www.esmo.org . About Medarex Medarex is a biopharmaceutical company focused on the discovery, development and pote...

European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGene's Cancer-Killing Virus in Press Conference

...e I/II trial of oncolytic HSV * Poster selected by esmo for presentation in press conference MARTINSRIED...take place on Friday, July 6, at 12:30 MEST at the esmo conference in Lugano, Switzerland (ECLU). Dr. Axel...nalysis of this study. The poster presented at the esmo conference shows efficacy data in a case study for...

MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial

...a preliminary study, researchers said today at the esmo Conference Lugano (ECLU), Switzerland. The virus...ltidisciplinary cancer treatment around the world. esmo unites medical oncologists, oncology specialists, ... state-of-the-art education and training programs, esmo plays an instrumental role in providing the oncolo...
ESMO in Biological News

European Multidisciplinary Conference on Thoracic Oncology

...resenters of the studies, both in presence and remotely. Please contact the esmo Communication Dept. at media@esmo.org to already find out about the preli...newsroom/events/ and send the Complimentary Media Registration form to the esmo Communication Department. Accommodation For hotel reservation, pleas...

New treatment approach promising for lymphoma patients in the developing world

...patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say. At the esmo Conference Lugano (ECLU) organized by the European Society for Medical Oncology, a group headed by Prof. Hamdy Azim from Cairo University reports that...

Treatment delays result in poor outcomes for men with breast cancer

...lthough most breast cancer patients are women, men make up roughly 1% of cases, Dr. Marina Garassino from the Orion Collaborative Group reports at the esmo Conference Lugano (ECLU), organized by the European Society for Medical Oncology. Her group conducted a retrospective analysis of 146 men with inv...

Counting tumor cells in blood predicts treatment benefit in prostate cancer

...am of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show. At the esmo Conference Lugano (ECLU) organized by the European Society for Medical Oncology, researchers showed that changes in the number of circulating tumor ce...

First European Lung Cancer Conference

...for Medical Oncology (ESMO), the European Lung Cancer Conference will be held biennially, alternating with the World Conference on Lung Cancer and the esmo chest tumors conference. The event will gather top multidisciplinary experts to provide the audience (European and worldwide) with state-of-the-art ed...

ESMO International Symposium on Immunology

...cs in the field of tumor immunology and immunotherapy will be discussed by international experts to the benefit of young cancer specialists during the esmo International Symposium (EIS) on Immunology. Immunology has come to stay in oncology: this EIS symposium will offer a comprehensive overview of the in...
ESMO in Biological Technology

33rd ESMO Congress in Stockholm, 12-16 September 2008

LUGANO, Switzerland, September 5 /PRNewswire/ -- The 33rd ESMO Congress in Stockholm, the premier European congress in Oncology, serves as a meeting place for medical oncologists, as well as a focal point to exchange ideas with colleagues from other disciplines. The Congress Centre will be t...

Palonosetron Warrants Adequate Caloric Intake in Oncology Patients Receiving High Emetogenic Chemotherapy

...s adequate caloric intake in oncology patients. Data presented today at the esmo Symposium on Cancer and Nutrition in Zurich, Switzerland New data presented today at the esmo (European Society of Medical Oncology) Symposium on Cancer and Nutrition in...
Other Tags
(Date:7/12/2014)... rise in the number of mobility devices around the ... suit the upsurge. Virtualization has become a growing trend ... The data traffic has increased by several folds with ... in larger and more complex networks. These global factors ... , The North American (NA) region is expected to ...
(Date:7/12/2014)... In this cognitive assessment ... and training’ is defined as solution that ... enhance cognitive functions. These solutions are applied ... screening, clinical trials, driver’s safety, rehabilitation, academic ... brain training, and employers’ assessment and training ...
(Date:7/12/2014)... York, New York (PRWEB) July 12, 2014 ... liver damage allegations continue to move forward in ... Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP ... 2014, U.S. District Judge Lawrence F. Stengel has ... Among other things, Judge Stengel found that the ...
(Date:7/12/2014)... PA (PRWEB) July 12, 2014 "The second ... it’s uncomfortable and painful to wear shoes," said an inventor ... special sock that prevents this from happening. , He then ... effective way to prevent the second and big toes from ... endurance while wearing shoes. Ergonomic and easy to use, it's ...
(Date:7/12/2014)... York (PRWEB) July 12, 2014 As ... move forward in U.S. courts, Bernstein Liebhard LLP notes ... metal ion levels to the failure of metal-on-metal hip ... issue of The Journal of Bone & Joint Surgery, ... unilateral Articular Surface Replacement prostheses at least twelve months ...
Breaking Medicine News(10 mins):Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 4Health News:North America Software Defined Network (SDN) Market Worth $1,443.8 Million by 2019 - New Report by MicroMarket Monitor 5Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 2Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 3Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 4Health News:Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com 5Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 2Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 3Health News:Tylenol Lawsuit News: U.S. District Judge Overseeing Federal Tylenol Liver Damage Litigation Orders Deposition of Former McNeil President, Bernstein Liebhard LLP Reports 4Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4
(Date:7/11/2014)... July 11, 2014 Researchers have pioneered a ... The new technology, called Virtual Finger, allows scientists ... like neurons and synapses using the flat surface ... makes 3D imaging studies orders of magnitude more ... unprecedented level across many areas of experimental biology. ...
(Date:7/11/2014)... hippocampus, the marginal division of the striatum is ... the impact degree of substance P in the ... Yan Yu and his team, College of Biophotonics, ... staining, that substance P receptor, neurokinin 1 was ... division of normal rats. Unilateral or bilateral injection ...
(Date:7/11/2014)... , July 11, 2014 Research and ... "International Biometrics Technology Market - Industry Analysis Size Share ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... crimes has created a need for high level security ... for personnel authentication such as username and passwords, tokens ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
Other Contents